Could a common EoE treatment stunt Kids' growth?
NCT ID NCT03615950
Summary
This study aimed to understand the long-term safety of a common treatment for eosinophilic esophagitis (EoE) in children. Researchers planned to compare bone density and growth rates over one year in children aged 5-12 taking swallowed steroids for EoE against similar children not on this treatment. The goal was to see if this medication, absorbed through the throat, could have side effects similar to other steroid forms. The trial was withdrawn and did not enroll any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
Conditions
Explore the condition pages connected to this study.